F2RL3 and intestinal cancer: The mechanism of platelet activation triggered by intestinal cancer cells is dependent on the expression of cancer cell TF, with thrombin production activating protease-activated receptor 4 (PAR4) on platelets, thereby promoting ADP and thromboxane A2 (TXA2) release [31].